Sign In
Buy MASS
$8.01
+0.370 (+4.84%)
At Close: Jul 31, 2026
908 Devices Inc. (MASS) Q1 2024 Earnings Call Transcript
01:21pm, Tuesday, 30'th Apr 2024
908 Devices Inc. (NASDAQ:MASS ) Q1 2024 Results Conference Call April 30, 2024 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Co-Founder and Chief Executive Officer Joe
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
09:56am, Tuesday, 30'th Apr 2024
908 Devices Inc. (MASS) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.39 per share a year ago.
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
07:45am, Tuesday, 30'th Apr 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
07:30am, Tuesday, 30'th Apr 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biochemical analysis, announces that it has completed the a
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
07:00am, Tuesday, 23'rd Apr 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the firs
908 Devices: Rare Early-Stage Bioprocess Investment Opportunity
12:49pm, Wednesday, 10'th Apr 2024
Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are leading companies in the life science tools industry. Despite a long history of success with those firms, I believe long-ter
3 Stocks Under $10 That Wall Street Sees More Than 100% Upside This Year
10:32am, Thursday, 21'st Mar 2024
Robinhood revolutionized commission free investing, and it continues to do so today.
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
07:00am, Tuesday, 12'th Mar 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption
908 Devices Inc. (MASS) Q4 2023 Earnings Call Transcript
03:20pm, Tuesday, 05'th Mar 2024
908 Devices Inc. (NASDAQ:MASS ) Q4 2023 Earnings Conference Call March 5, 2024 8:00 AM ET Company Participants Kelly Gura - IR Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
07:00am, Tuesday, 05'th Mar 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte
BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #bioprocessing--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis,
908 Devices to Participate in Upcoming Investor Conferences
07:00am, Thursday, 22'nd Feb 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the foll
908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
07:00am, Tuesday, 20'th Feb 2024
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the four
908 Devices Inc. (MASS) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Thursday, 28'th Dec 2023
908 Devices Inc. (MASS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
10:30am, Wednesday, 27'th Dec 2023
Cathie Wood's Ark Invest has been at the center of the thematic investing revolution. Two of Wood's healthcare picks, 908 Devices and Beam Therapeutics, have garnered lofty price targets from analysts
